Endoluminal and Interstitial Brachytherapy for the Treatment of Gastrointestinal Malignancies: a Systematic Review

Curr Oncol Rep. 2017 Jan;19(1):2. doi: 10.1007/s11912-017-0561-1.

Abstract

Radiation therapy is an integral component in the multimodality management of many gastrointestinal (GI) cancers at all stages of clinical presentation. With recent advances in technology and radiation delivery, external beam radiation therapy (EBRT) can be delivered with reduced toxicity. However, despite these advances, EBRT doses are still limited by the presence of radiosensitive serial structures near clinical targets in the GI tract. Relative to EBRT techniques, brachytherapy techniques have a lower integral dose and more rapid fall-off, allowing for high-dose delivery with little normal tissue exposure. Given the unique characteristics of brachytherapy, it is an attractive strategy to treat GI malignancies. This review addresses the application of both high-dose rate brachytherapy (HDRBT) and low-dose rate brachytherapy (LDRBT) to multiple GI malignancies for both definitive and palliative management.

Keywords: Biliary brachytherapy; Brachytherapy; Endoesophageal brachytherapy; Endoluminal brachytherapy; Endorectal brachytherapy; Gastrointestinal malignancy; High-dose rate brachytherapy; Interstitial brachytherapy; Low-dose rate brachytherapy; Palliative care.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Brachytherapy / adverse effects
  • Brachytherapy / methods*
  • Combined Modality Therapy
  • Gastrointestinal Neoplasms / drug therapy
  • Gastrointestinal Neoplasms / pathology
  • Gastrointestinal Neoplasms / radiotherapy*
  • Gastrointestinal Tract / pathology
  • Gastrointestinal Tract / radiation effects*
  • Humans
  • Radiation Injuries*
  • Radiotherapy Dosage